Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Nucleic Acids Research|June 18, 2025
Landscape of A-I RNA editing in mouse, pig, macaque, and human brainsConghui Li, Wei Lv, Zhiwei He, et al.Heliyon|January 8, 2024
Identification of the transcriptome signatures and immune-inflammatory responses in postmenopausal osteoporosisPan Gao, Xiaoguang Pan, Shang Wang, et al.Clinical and Translational Medicine|October 20, 2023
Plasma extrachromosomal circular DNA is a pathophysiological hallmark of short-term intensive insulin therapy for type 2 diabetesZhe Xu, Junyu He, Peng Han, et al.Molecular Therapy. Nucleic Acids|April 19, 2021
Efficient correction of Duchenne muscular dystrophy mutations by SpCas9 and dual gRNAsXi Xiang, Xiaoying Zhao, Xiaoguang Pan, et al.Cellular and Molecular Life Sciences : CMLS|March 20, 2019
LION: a simple and rapid method to achieve CRISPR gene editingXi Xiang, Lidan Luo, Michał Nodzyński, et al.Cell Reports|December 11, 2025
Extrachromosomal circular miRNA-gene amplifications contribute to the renal cancer phenotypePeng Han, Wei Lv, Zhe Xu, et al.Nucleic Acids Research|January 17, 2020
Haplotyping by CRISPR-mediated DNA circularization (CRISPR-hapC) broadens allele-specific gene editingJiaying Yu, Xi Xiang, Jinrong Huang, et al.Nature Communications|September 6, 2024
Hyper-recombination in ribosomal DNA is driven by long-range resection-independent RAD51 accumulationZita Gál, Stavroula Boukoura, Kezia Catharina Oxe, et al.Nature Communications|May 29, 2021
Enhancing CRISPR-Cas9 gRNA efficiency prediction by data integration and deep learningXi Xiang, Giulia I Corsi, Christian Anthon, et al.Nature Communications|July 13, 2022
Massively targeted evaluation of therapeutic CRISPR off-targets in cellsXiaoguang Pan, Kunli Qu, Hao Yuan, et al.Pageof 4